General News

Eutelsat Communications S.A. (LSE:ETL) has launched ashare capitalincrease withshareholders’ preferential subscription rights for approximately EUR 670M (the “Rights Issue”). The transaction follows the completion of EUR 828M reservedcapitalincreases in November 2025, which were subscribed by the French State via the Agence des Participations de …

Trellus Health® plc (LSE:TRLS), a digital healthcare company delivering Trellus Elevate®, announced an unsecuredloanagreement with substantialshareholderIcahn School of Medicine at Mount Sinai (“Mount Sinai”) totaling USD 600,000. The Loan Note is structured to be non-interest bearing for six months, after which it will accrue …

Orcadian Energy plc (LSE:ORCA) has received approval from the North Sea Transition Authority (NSTA) for a three-year extension of the Second Term of Pilot Licence P2244. The new licence expiry date is 1 December 2028. This extension provides additional time for the operator to …

Microlise Group plc (LSE:SAAS) has provided an update on its trading for the year ending 31 December 2025. Based on year-to-date trading and the pipeline for the remainder of FY25, the Group now expects totalrevenuesto be below current market expectations, at not less than …

S4 Capital PLC (LSE:SFOR) has updated its 2025 financial outlook following the release of third quarter results and October financial performance. The company now anticipates like-for-like netrevenuefor 2025 to decline by just under 10% compared with previous forecasts. The reduction is attributed to lower …

M&C Saatchi (LSE:SAA) has issued updated guidance for the twelve months ending 31 December 2025. Trading in the second half of the year was affected by the unprecedented US Government shutdown, which had a notable impact on the Company’s Issues specialism, a key contributor …

ImmuPharma PLC (LSE:IMM), a specialist drug discovery and development company, provided an update on its P140 partnership discussions. In a previous notification on 23 October 2025, the company indicated it had engaged with multiple potential partners, including several top ten global pharmaceutical companies, aiming …